BenefitsLink logo
EmployeeBenefitsJobs logo
Free Daily News and Jobs

“BenefitsLink continues to be the most valuable resource we have at the firm.”
-- An attorney subscriber
Featured Jobs

Sales - 401(k) / DB Administration (FL / GA / MO / NC)

401(k) Retirement Plan Administrator (Deerfield IL)

NQ Plan Administrator (Lake Mary FL / Richmond VA / Dallas TX)
Get the BenefitsLink app LinkedIn
Twitter
Facebook

News Items, by Subject

Health plan costs - prescription drugs


Now Viewing
Headlines
View Excerpts and
Headlines

Supreme Court Deals a Fatal Blow to Maryland Drug 'Price Gouging' Law
Lowering Drug Costs: New Proposed Rule Targets Drug Rebates
Express Scripts Reports Record Low Drug Trend Across Commercial Plans in 2018
Remote Prescribing Trends in Telehealth
House Ways & Means Committee Hearing: The Cost of Rising Prescription Drug Prices
[Guidance Overview] HHS Proposes Rule to Eliminate Safe Harbor for PBM Drug Rebates
Administration Salutes Parade of Generic Drug Approvals, But Hundreds Aren't Yet on the Market
[Guidance Overview] HHS Aims to Reduce Prescription Drug Prices Through Proposed Changes to the Anti-Kickback Statute's Safe Harbors
[Guidance Overview] HHS OIG Proposes Anti-Kickback Safe Harbor Amendments to Regulate and Restrict the Provision of Manufacturer Remuneration to Plan Sponsors and PBMs
[Guidance Overview] HHS Proposes New Rules to Eliminate Drug Rebates and Encourage Direct Discounts
[Guidance Overview] Sweeping Changes Proposed to Safe Harbors for Drug Discounts to Health Plans
[Guidance Overview] HHS Proposes Rule Challenging Drug Manufacturer Rebates to PBMs and Payors
[Guidance Overview] Administration Releases Long-Awaited Drug Rebate Proposal
Winners and Losers Under HHS Plan to Slash Drug Rebate Deals
Impact of Potential Changes to the Treatment of Drug Manufacturer Rebates (PDF)
HHS Proposal Could Kill PBM Rebates
[Official Guidance] Text of HHS Proposed Regs: Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection for Certain Point-of-Sale Reductions in Price on Prescription Pharmaceuticals and Certain PBM Fees
[Guidance Overview] Administration Proposes to Lower Drug Costs by Targeting Backdoor Rebates and Encouraging Direct Discounts to Patients
Provider Payments Criticized as Congress Targets High Drug Costs
[Opinion] Comprehensive Reform to Lower Prescription Drug Prices
Essential Facts About Medicare and Prescription Drug Spending
Congress Wades Into Debate Over High-Cost Prescription Drugs; Pharma Execs Refuse to Testify
Senate Finance Committee Hearing: Drug Pricing in America -- A Prescription for Change, Part I
California Makes Waves with Pharma Benefits, Purchasing Plan
CMS Addresses Drug Manufacturer Coupons in Proposed 2020 Payment Notice
TRICARE Issues Request for Information on Formulary Management
Including Drug Prices in TV Ads May Deter Consumers from High-Priced Drugs
HHS Proposals Could Increase Health Costs for Consumers
California Prescription Drug Purchasing Initiative Raises Numerous Questions
[Guidance Overview] CMS Announces New Model to Lower Drug Prices in Medicare Part D and Transformative Updates to Existing Model for Medicare Advantage
Drug-Pricing Transparency, Vertical PBM Deals Are Top of Mind for Employers in 2019
Bringing 'Transparent Thinking' to PBM Management (PDF)
HHS Secretary Raises Possibility of Allowing Drug Importation to Help Rein in Drug Prices
HHS Medicare Drug Shift Plan Could Reduce Costs Overall But Raise Them for Some
Sen. Sanders, Rep. Cummings to Introduce Bill to Lower U.S. Drug Prices
Health Care Industry Spends $30 Billion Each Year Pushing Its Wares, From Drugs to Stem Cell Treatment
Drug Costs Driven Largely By Price Increases, Not Innovation
Policy Options for Increasing Generic Drug Competition Through Importation
Prescription Drug Policy: The Year in Review, and the Year Ahead
Dozens of Pharmaceutical Makers Raise Prices on Hundreds of Drugs to Ring in the New Year
Judge OKs CVS Plan to Keep Aetna Separate Pending Review
Onsite Dispensaries Help Employees Use Medications Properly
New PBM Models Respond to Public Pressure, Market Demand
Possible Steep Consequences for U.S. Pharmaceutical and Biologics Industries from ACA Decision
For the Asking, a Check Is in the Mail to Help Pay for Costly Drugs
[Opinion] Prescription Drugs and Price Controls: What the Debate Gets Wrong
[Official Guidance] Text of Department of Defense Interim Final Rule: TRICARE Pharmacy Benefits Program Reforms
Telemedicine Could See Uptick in 2019 with Change in Rules for Online Prescribing
Double Jeopardy in Health: It's Time for Employers to Care
CMS Office of the Actuary Releases 2017 National Health Expenditures
Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses: Highlights from the Proposed Rule
Drug Companies Draw Fire for Not Using Tax Savings to Lower Drug Prices
[Guidance Overview] CMS Releases Medicare Advantage and Part D Drug Pricing Proposed Rule for Contract Year 2020
CVS Offers 'Guaranteed Net Cost' for Pharmacy Benefit Clients
[Guidance Overview] CMS Issues Proposed Rule on Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses
[Guidance Overview] Administration Proposes Strategies to Lower Pharmaceutical Prices in Medicare Part D
Medicare Plans Could Gain Drug Pricing Leverage Under CMS Proposal
Cost-Sharing and Drug-Price Transparency in New York
CMS Takes Action to Lower Prescription Drug Costs by Modernizing Medicare
[Guidance Overview] Text of CMS Fact Sheet: Contract Year 2020 Medicare Advantage and Part D Drug Pricing Proposed Rule
 
About Us

Testimonials

Privacy Policy

Post a Job

Advertise in the BenefitsLink Newsletters

Add Your Company to the Directory of Vendors and Software

Submit a News Item, Press Release, Webcast or Conference

Contact Us

Payment Portal

© 2019 BenefitsLink.com, Inc.